Resolution to require the National Government to establish compulsory licenses and other measures to guarantee free and affordable access to pharmaceutical products and medical technologies in the Declaration of Sanitary Emergency due to the Coronavirus pandemic (COVID-19) and other variations,… Continue Reading →
COVID-19 Gov’t Contracts: KEI has obtained numerous contracts between the federal government and pharmaceutical companies regarding COVID-19 medical technologies via the Freedom of Information act. For these and other contracts, please see: https://www.keionline.org/covid-contracts. COVID-19 Vaccine Manufacturing: KEI has gathered data… Continue Reading →
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. Global health emergencies such as the COVID-19 pandemic call upon us to answer to the better angels of our nature. Not all are heeding that call. Instead of cooperation and selflessness,… Continue Reading →
For more on KEI’s work on COVID-19, see keonline.org/coronavirus. The “Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020’’ will provide welcome funding to deal with the expanding COVID-19 pandemic. The current language on affordability (this Draft text), however, is worse… Continue Reading →
Filed in 84 FR 68128, Docket No. 191126-0092. KEI-NIST-RFC-iEdison, 27Jan2020 January 27, 2020 Dr. Courtney Silverthorn Deputy Director, Technology Partnerships Office, National Institute of Standards and Technology Technology Partnerships Office 100 Bureau Drive, MS 2200, Gaithersburg, MD 20899, mailto:courtney.silverthorn@nist.gov Re:… Continue Reading →
KEI filed these comments on the NIH Draft Policy for Data Management and Sharing and Supplemental DRAFT Guidance January 10, 2019 1621 Connecticut Avenue NW Suite 500 Washington, DC 20009 www.keionline.org January 10, 2020 Office of Science Policy National Institutes… Continue Reading →
KEI Comments on Intellectual Property Protection for Artificial Intelligence Innovation, for USPTO Request for Comments Re: 84 FR 66176, Docket No. PTO-C-2019-0038 10 January 2020 1. Should a work produced by an AI algorithm or process, without the involvement of… Continue Reading →
The 146th session of the World Health Organization’s (WHO) Executive Board will take place from 3 February 2020 to 8 February 2020 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading →
On Tuesday November 12, 2019, KEI and the Union for Affordable Cancer Treatment (UACT) filed comments on the National Institutes of Health’s (NIH) “Prospective Grant of an Exclusive Patent License: The Development of an Anti-GPC3 Radionuclide Immunoconjugate for the Treatment… Continue Reading →
Today at the WIPO Standing Committee on Copyright and Related Rights (SCCR) started the discussion on the broadcasters’ treaty. According to the Chair, at the last General Assembly, the Committee received “a mandate to continue making progress towards convening a… Continue Reading →
